Cargando…
吉非替尼治疗非小细胞肺癌的meta分析
BACKGROUND AND OBJECTIVE: Malignant grade and death rate are very high for non-small cell lung cancer, and geftinib is a new molecule target anticancer drug. The aim of this meta analysis is to evaluate the clinical efficacy and safety of geftinib for non-small cell lung cancer. METHODS: We searched...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999715/ https://www.ncbi.nlm.nih.gov/pubmed/21496435 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.04.09 |